Trading in Novo Nordisk shares by board members, executives and associated persons
May 06, 2024 15:02 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 May 2024 – This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons...
Novo Nordisk A/S - share repurchase programme
May 06, 2024 14:44 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 May 2024 – The execution of Novo Nordisk A/S’ overall share repurchase programme for 2024 of DKK 20 billion continues. As part of this, Novo Nordisk A/S has now initiated a new...
Novo Nordisk A/S purchases B shares worth DKK 5,428 million from Novo Holdings A/S under the 2024 share repurchase programme
May 06, 2024 14:40 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 06 May 2024 – Today, Novo Nordisk A/S has entered into an agreement to purchase 6,311,250 B shares of DKK 0.10 at a value of DKK 5,427,801,225.00 million from Novo Holdings A/S. The...
Novo Nordisk A/S: Trading in Novo Nordisk shares by board members, executives and associated persons
May 03, 2024 13:48 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 3 May 2024 — This company announcement discloses the data of the transaction(s) made in Novo Nordisk shares by the company’s board members, executives and their associated persons...
Novo Nordisk's sales increased by 22% in Danish kroner and by 24% at constant exchange rates to DKK 65.3 billion in the first three months of 2024
May 02, 2024 01:30 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 2 May 2024 - financial report for the period 1 January 2024 to 31 March 2024 Operating profit increased by 27% in Danish kroner and by 30% at constant exchange rates (CER) to DKK...
Novo Nordisk A/S - share repurchase programme
May 01, 2024 08:30 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 1 May 2024 – On 6 February 2024, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of...
Novo Nordisk A/S – Total number of voting rights and share capital in Novo Nordisk A/S as of 26 April 2024
April 26, 2024 06:16 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 26 April 2024 – In accordance with Section 32 of the Danish Capital Markets Act, Novo Nordisk A/S is required to publish the total number of voting rights and the size of the share...
Vedtægter for Novo Nordisk, april 2024
April 24, 2024 08:57 ET
|
Novo Nordisk A/S
Vedtægter for Novo Nordisk, april 2024
Vedhæftet fil
Vedtægter 24 Apr 2024
...
Novo Nordisk A/S - Articles of Association, April 2024
April 24, 2024 08:57 ET
|
Novo Nordisk A/S
Novo Nordisk's Articles of Association, April 2024
Attachment
Articles of Association 24 Apr 2024
...
Novo Nordisk A/S – Reduction of the share capital
April 24, 2024 08:48 ET
|
Novo Nordisk A/S
Bagsværd, Denmark, 24 April 2024 – At Novo Nordisk’s Annual General Meeting on 21 March 2024, it was decided to reduce the company’s B share capital from DKK 343,512,800 to DKK 339,012,800 by...